Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Enfusion Q1 2024 Adj EPS $0.06 Beats $0.04 Estimate, Sales $48.052M Beat $47.616M Estimate

Author: Benzinga Newsdesk | May 09, 2024 07:34am
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 100 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $48.052 million which beat the analyst consensus estimate of $47.616 million by 0.92 percent. This is a 17.28 percent increase over sales of $40.971 million the same period last year.

Posted In: ENFN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist